These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 16730929

  • 1. Clitoral circulation in postmenopausal women with sexual dysfunction: a pilot randomized study with hormone therapy.
    Nappi RE, Ferdeghini F, Sampaolo P, Vaccaro P, De Leonardis C, Albani F, Salonia A, Polatti F.
    Maturitas; 2006 Oct 20; 55(3):288-95. PubMed ID: 16730929
    [Abstract] [Full Text] [Related]

  • 2. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S, Moghasemi M, Faghihzadeh S.
    Climacteric; 2010 Apr 20; 13(2):147-56. PubMed ID: 19731119
    [Abstract] [Full Text] [Related]

  • 3. Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women.
    Osmanağaoğlu MA, Atasaral T, Baltaci D, Bozkaya H.
    Climacteric; 2006 Dec 20; 9(6):464-72. PubMed ID: 17085380
    [Abstract] [Full Text] [Related]

  • 4. Effects of tibolone and raloxifene on health-related quality of life and sexual function.
    Nijland EA, Weijmar Schultz WC, Davis SR.
    Maturitas; 2007 Oct 20; 58(2):164-73. PubMed ID: 17870260
    [Abstract] [Full Text] [Related]

  • 5. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
    Wu MH, Pan HA, Wang ST, Hsu CC, Chang FM, Huang KE.
    Climacteric; 2001 Dec 20; 4(4):314-9. PubMed ID: 11770188
    [Abstract] [Full Text] [Related]

  • 6. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE, Botsis DS, Lambrinoudaki IV, Papagianni VD, Panoulis CP, Creatsa MG, Alexandrou AP, Augoulea AD, Dendrinos SG, Creatsas GC.
    Maturitas; 2006 Mar 20; 53(4):413-23. PubMed ID: 16140483
    [Abstract] [Full Text] [Related]

  • 7. Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches.
    Nappi RE, Sances G, Sommacal A, Detaddei S, Facchinetti F, Cristina S, Polatti F, Nappi G.
    Menopause; 2006 Mar 20; 13(5):818-25. PubMed ID: 16894336
    [Abstract] [Full Text] [Related]

  • 8. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
    Gregersen N, Jensen PT, Giraldi AE.
    Dan Med Bull; 2006 Aug 20; 53(3):349-53. PubMed ID: 17092454
    [Abstract] [Full Text] [Related]

  • 9. Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality.
    Genazzani AR, Stomati M, Valentino V, Pluchino N, Pot E, Casarosa E, Merlini S, Giannini A, Luisi M.
    Climacteric; 2011 Dec 20; 14(6):661-8. PubMed ID: 21942655
    [Abstract] [Full Text] [Related]

  • 10. Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients.
    Schroder M, Mell LK, Hurteau JA, Collins YC, Rotmensch J, Waggoner SE, Yamada SD, Small W, Mundt AJ.
    Int J Radiat Oncol Biol Phys; 2005 Mar 15; 61(4):1078-86. PubMed ID: 15752887
    [Abstract] [Full Text] [Related]

  • 11. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
    Vieira CS, Pereira FV, de Sá MF, Paulo LJ, Martins WP, Ferriani RA.
    Maturitas; 2009 Mar 20; 62(3):311-6. PubMed ID: 19193505
    [Abstract] [Full Text] [Related]

  • 12. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar 20; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

  • 13. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.
    Nijland EA, Weijmar Schultz WC, Nathorst-Boös J, Helmond FA, Van Lunsen RH, Palacios S, Norman RJ, Mulder RJ, Davis SR, LISA study investigators.
    J Sex Med; 2008 Mar 20; 5(3):646-56. PubMed ID: 18304284
    [Abstract] [Full Text] [Related]

  • 14. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group.
    Kenemans P, Speroff L, International Tibolone Consensus Group.
    Maturitas; 2005 May 16; 51(1):21-8. PubMed ID: 15883105
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women.
    Cayan F, Dilek U, Pata O, Dilek S.
    J Sex Med; 2008 Jan 16; 5(1):132-8. PubMed ID: 17961145
    [Abstract] [Full Text] [Related]

  • 16. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF, Andrade AT, Ribeiro LC, Castro IQ, Brandão M, Polisseni F, Guerra Mde O.
    Maturitas; 2013 Feb 16; 74(2):172-8. PubMed ID: 23201326
    [Abstract] [Full Text] [Related]

  • 17. Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction.
    Nijland EA, Nathorst-Böös J, Palacios S, van de Weijer PW, Davis S, Stathopoulos VM, Birkhaeuser MH, von Mauw E, Mulder RJ, Schultz WC, LISA study investigators group.
    Climacteric; 2009 Apr 16; 12(2):114-21. PubMed ID: 19177255
    [Abstract] [Full Text] [Related]

  • 18. Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study.
    Koh KK, Han SH, Shin MS, Ahn JY, Lee Y, Shin EK.
    Eur Heart J; 2005 Jul 16; 26(14):1362-8. PubMed ID: 15872028
    [Abstract] [Full Text] [Related]

  • 19. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D, Yeşildaglar N, Erkaya S.
    Gynecol Endocrinol; 2005 Apr 16; 20(4):209-12. PubMed ID: 16019363
    [Abstract] [Full Text] [Related]

  • 20. Effects of tibolone on the breast of postmenopausal women.
    Wang PH, Cheng MH, Chao HT, Chao KC.
    Taiwan J Obstet Gynecol; 2007 Jun 16; 46(2):121-6. PubMed ID: 17638619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.